GlassScriptPhysician profile
Vardui Asiryan
NPI 1487880506
$21,358.97
in general payments reported to CMS, 2019-2025
23 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $134 · 2021: $394 · 2022: $207 · 2023: $356 · 2024: $8,235 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,200.00 |
| Food and Beverage | $2,057.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $18,200.00 | 2024-2025 | Bovine Collagen |
| Shield Therapeutics INC | $532.75 | 2024-2025 | |
| Abbvie INC. | $477.94 | 2019-2023 | Lo Loestrin Fe |
| Coopersurgical, INC. | $328.68 | 2019-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Pfizer INC. | $317.14 | 2019-2025 | |
| Astellas Pharma US INC | $263.12 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $238.17 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Agile Therapeutics, INC. | $165.07 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $156.60 | 2021-2025 | |
| Amgen INC. | $146.66 | 2019-2025 | |
| Therapeuticsmd, INC. | $79.74 | 2020-2021 | |
| Lupin INC. | $68.73 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $54.66 | 2019 | |
| Allergan, INC. | $50.92 | 2019-2020 | |
| Myovant Sciences INC. | $44.71 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $43.54 | 2025 | Myfembree |
| Sage Therapeutics, LLC | $41.89 | 2024 | |
| Caris Mpi, INC. | $40.85 | 2025 | Mi Cancer Seek |
| Exeltis, USA INC. | $39.67 | 2023-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $24.22 | 2021 | |
| Meditrina | $15.86 | 2025 | |
| Virtus Pharmaceuticals LLC | $15.56 | 2021 | |
| Evofem Biosciences, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vardui Asiryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.